Kenvue Inc. $KVUE Stock Holdings Increased by GAMMA Investing LLC

GAMMA Investing LLC boosted its stake in shares of Kenvue Inc. (NYSE:KVUE) by 127.1% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 52,490 shares of the company’s stock after purchasing an additional 29,378 shares during the period. GAMMA Investing LLC’s holdings in Kenvue were worth $905,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. American Century Companies Inc. grew its holdings in shares of Kenvue by 22.4% during the 3rd quarter. American Century Companies Inc. now owns 37,046,660 shares of the company’s stock valued at $601,267,000 after acquiring an additional 6,781,640 shares in the last quarter. Independent Franchise Partners LLP increased its stake in shares of Kenvue by 233.4% in the second quarter. Independent Franchise Partners LLP now owns 31,265,574 shares of the company’s stock worth $654,388,000 after acquiring an additional 21,886,537 shares during the last quarter. Norges Bank purchased a new stake in shares of Kenvue during the second quarter worth $537,418,000. Dimensional Fund Advisors LP raised its holdings in shares of Kenvue by 13.5% during the third quarter. Dimensional Fund Advisors LP now owns 23,127,234 shares of the company’s stock worth $375,377,000 after acquiring an additional 2,747,952 shares in the last quarter. Finally, Van ECK Associates Corp raised its holdings in shares of Kenvue by 101.3% during the third quarter. Van ECK Associates Corp now owns 18,361,581 shares of the company’s stock worth $298,008,000 after acquiring an additional 9,240,434 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on KVUE. Weiss Ratings restated a “hold (c-)” rating on shares of Kenvue in a research note on Friday, January 9th. Canaccord Genuity Group raised their price target on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research note on Wednesday, February 18th. Jefferies Financial Group lowered Kenvue from a “buy” rating to a “hold” rating and reduced their price target for the company from $23.00 to $18.00 in a report on Friday, January 30th. Barclays increased their price objective on Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a report on Friday, March 6th. Finally, UBS Group raised their price objective on shares of Kenvue from $17.00 to $19.00 and gave the company a “neutral” rating in a research report on Wednesday, February 18th. Three investment analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Kenvue presently has a consensus rating of “Hold” and an average price target of $19.58.

Kenvue Price Performance

NYSE KVUE opened at $17.43 on Monday. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $25.17. The stock’s 50-day moving average is $17.97 and its two-hundred day moving average is $17.17. The firm has a market cap of $33.40 billion, a P/E ratio of 22.63, a price-to-earnings-growth ratio of 3.95 and a beta of 0.51. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.96 and a quick ratio of 0.68.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $0.05. The company had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $3.68 billion. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The firm’s revenue was up 3.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.26 EPS. On average, analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th were given a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a yield of 4.8%. Kenvue’s dividend payout ratio is presently 107.79%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.